Progression of putaminal degeneration in multiple system atrophy: A serial diffusion MR study

By using diffusion-weighted imaging (DWI), we have recently shown abnormal diffusivity in the putamen of patients with the Parkinson variant of multiple system atrophy (MSA-P) which also correlated with disease severity, indicating the capability of putaminal diffusivity to serve as a marker for disease progression. We therefore performed a serial DWI study in 10 patients with MSA-P compared to 10 patients with Parkinson's disease (PD) to evaluate the dynamic evolution of diffusion properties in the basal ganglia including putamen, caudate nucleus and globus pallidum by means of the trace of the diffusion tensor (Trace(D)). For comparison, we have also analyzed the frequency and semiquantitative grading of MSA-P-related structural changes on conventional MRI including putaminal atrophy, lateral hyperintense margination of the putamen and putaminal signal hypointensity relative to the globus pallidum on T2 MR images. None of the Trace(D) values in the basal ganglia regions in the PD group changed significantly at follow-up compared to baseline. In MSA-P, a significant increase of the Trace(D) was found in the putamen, which correlated with motor progression as assessed by the Unified Parkinson's Disease Rating Scale (UPDRS). No significant change of any of the abnormal putaminal findings on routine MRI was obtained. We suggest that abnormal diffusivity in the putamen is sensitive to change over time in MSA-P and correlates with motor progression indicating that DWI may serve to monitor disease progression in MSA-P in an objective and quantitative manner.

[1]  C Kremser,et al.  Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy , 2003, Neurology.

[2]  Francesco Federico,et al.  Proton magnetic resonance spectroscopy in parkinson's disease and atypical parkinsonian disorders , 1997 .

[3]  C Kremser,et al.  Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD , 2002, Neurology.

[4]  R I Grossman,et al.  Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes , 1989, Neurology.

[5]  C. Büchel,et al.  Voxel‐based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy , 2003, Movement disorders : official journal of the Movement Disorder Society.

[6]  J. Dichgans,et al.  The development of infratentorial atrophy in patients with idiopathic cerebellar ataxia of late onset: a CT study , 1990, Journal of Neurology.

[7]  N P Quinn,et al.  Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. , 1994, Brain : a journal of neurology.

[8]  Yoav Ben-Shlomo,et al.  Consensus statement on the diagnosis of multiple system atrophy , 1998, Clinical Autonomic Research.

[9]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[10]  Werner Jaschke,et al.  Comparison of diffusion‐weighted imaging and [123I]IBZM‐SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[11]  Dorothee P Auer,et al.  T2*-weighted MRI differentiates multiple system atrophy from Parkinson’s disease , 2002, Neurology.

[12]  K. Seppi,et al.  A novel grading scale for striatonigral degeneration (multiple system atrophy) , 2002, Journal of Neural Transmission.

[13]  R P Maguire,et al.  Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. , 1997, Brain : a journal of neurology.

[14]  J. Gore,et al.  In vivo measurement of ADC change due to intravascular susceptibility variation , 1999, Magnetic resonance in medicine.

[15]  A J Lees,et al.  Clinical usefulness of magnetic resonance imaging in multiple system atrophy , 1998, Journal of neurology, neurosurgery, and psychiatry.

[16]  John C. Gore,et al.  Effects of susceptibility variations on NMR measurements of diffusion , 1991 .

[17]  I Litvan,et al.  Progression of Hoehn and Yahr stages in parkinsonian disorders: A clinicopathologic study , 2000, Neurology.

[18]  Denis Le Bihan,et al.  Looking into the functional architecture of the brain with diffusion MRI , 2003, Nature Reviews Neuroscience.

[19]  Klaus Seppi,et al.  Progression of parkinsonism in multiple system atrophy , 2005, Journal of Neurology.

[20]  B. Drayer,et al.  Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. , 2002, Archives of neurology.

[21]  M. Skalej,et al.  Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy , 1999, Annals of neurology.

[22]  C. Marsden,et al.  Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy , 1995, Annals of neurology.

[23]  G. Filippini,et al.  Survival in multiple system atrophy: a study of prognostic factors in 59 cases , 1996, Journal of Neurology.

[24]  I. Aiba,et al.  Longitudinal MRI study of multiple system atrophy – when do the findings appear, and what is the course? , 2002, Journal of Neurology.

[25]  C. Good,et al.  Differentiation of atypical parkinsonian syndromes with routine MRI , 2000, Neurology.

[26]  W. Heiss,et al.  Differentiating multiple system atrophy from Parkinson’s disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging , 2002, Journal of neurology, neurosurgery, and psychiatry.

[27]  Mircea Ariel Schoenfeld,et al.  Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging , 2004, NeuroImage.

[28]  P. Lantos,et al.  The definition of multiple system atrophy: a review of recent developments. , 1998, Journal of neuropathology and experimental neurology.

[29]  N Hosten,et al.  Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  Y. Matsuoka,et al.  Survival of patients with multiple system atrophy. , 1994, Internal medicine.

[31]  D Petersen,et al.  Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[32]  N. Quinn,et al.  Multiple system atrophy: A review of 203 pathologically proven cases , 1997, Movement disorders : official journal of the Movement Disorder Society.

[33]  Willibald Gerschlager,et al.  Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: A longitudinal β‐CIT SPECT study , 2002, Movement disorders : official journal of the Movement Disorder Society.

[34]  Christian Kremser,et al.  Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease , 2004, NeuroImage.

[35]  Y. Abe,et al.  Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. , 2002, Brain : a journal of neurology.

[36]  Carlo Colosimo,et al.  Multiple system atrophy , 2004, The Lancet Neurology.